Tonix Pharmaceuticals strikes licensing deal to expand use of intranasal drug for metabolic disorders
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against...
Norway has raised concerns about Pfizer’s Covid-19 vaccine safety after 29 elderly people with serious...
Clinical stage company NewAmsterdam Pharma (NAP) has raised $196m (€160m) through Series A funding round...
Boehringer Ingelheim has entered into a strategic collaboration and licensing agreement with Enara Bio to...